Overview of Allergy and Anaphylaxis.
Autor: | Dribin TE; Division of Emergency Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, MLC 2008, Cincinnati, OH 45229-3039, USA., Motosue MS; Department of Allergy and Immunology, University of Hawaii, Kaiser Honolulu Clinic, 1010 Pensacola Street, Honolulu, HI 96814, USA; Department of Medicine, University of Hawaii, Kaiser Honolulu Clinic, 1010 Pensacola Street, Honolulu, HI 96814, USA., Campbell RL; Department of Emergency Medicine, Mayo Clinic, 200 First Street Southwest, Generose Building G-410, Rochester, MN, USA. Electronic address: Campbell.ronna@mayo.edu. |
---|---|
Jazyk: | angličtina |
Zdroj: | Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2023 Aug; Vol. 43 (3), pp. 435-451. |
DOI: | 10.1016/j.iac.2022.10.009 |
Abstrakt: | Allergic reactions and anaphylaxis occur on a severity continuum from mild and self-limited to potentially life-threatening or fatal reactions. Anaphylaxis is typically a multiorgan phenomenon involving a broad range of effector cells and mediators. Emergency department visits for anaphylaxis are increasing, especially among children. There is a broad differential diagnosis for anaphylaxis, and the diagnosis of anaphylaxis can be aided by the use of the National Institutes of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network clinical diagnostic criteria. Risk factors for severe anaphylaxis include older age, delayed epinephrine administration, and cardiopulmonary comorbidities. Competing Interests: Disclosure Dr. Campbell is an author for UpToDate and a consultant for Bryn Pharma. Dr. Dribin has received research funding from the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 2UL1TR001425-05A1 and Award Number 2KL2TR001426-05A1. (Copyright © 2022 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |